Physician profile
Safiya Steward
NPI 1497971576
$2,030.40
in general payments reported to CMS, 2019-2025
13 companies · $1,229 in 2025
The $1,229 reported for 2025 was more than what 88% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $125 · 2023: $244 · 2024: $432 · 2025: $1,229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,905.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $335.42 | 2025 | Tavneos, Evenity |
| Dexcom, INC. | $258.93 | 2023-2025 | Dexcom G6 Transmitter, Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
| Alexion Pharmaceuticals, INC. | $252.83 | 2025 | |
| Abbvie INC. | $248.47 | 2022-2024 | |
| Biomerieux INC | $162.00 | 2025 | |
| Hologic Sales and Service, LLC | $114.85 | 2025 | Aptima |
| Neurocrine Biosciences, INC. | $110.28 | 2024 | Ingrezza |
| Otsuka America Pharmaceutical, INC. | $103.32 | 2023 | Rexulti |
| Aimmune Therapeutics, INC. | $103.32 | 2024 | |
| Axsome Therapeutics, INC. | $100.68 | 2025 | Symbravo |
| Teva Pharmaceuticals USA, INC. | $96.21 | 2025 | |
| Phathom Pharmaceuticals, INC. | $95.40 | 2024 | Voquezna |
| Globus Medical, INC. | $48.69 | 2025 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Safiya Steward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.